Century Therapeutics shares nonclinical data for iPSC-derived diabetes therapy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: IPSC) | Delayed: 1.71 +0.10 (6.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.61 | 52 Week High | $ | |||
| Open | $1.61 | 52 Week Low | $ | |||
| Day High | $1.74 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $ | |||
| Volume | 407,865 | |||||
